OCUL
Ocular Therapeutix Inc
7.50$
+0.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -85.6% | -151.7% | -229.4% | -150.9% | -237.0% | -230.8% | -417.6% | -410.4% | -348.8% | -409.4% | -611.9% | -499.2% | -457.7% | |
| 5.9% | 6.5% | 6.2% | 5.8% | 6.2% | 5.6% | 9.2% | 7.6% | 7.4% | 9.4% | 11.9% | 13.7% | 10.5% | |
| 29.9% | 29.2% | 54.0% | 68.7% | 43.1% | 42.1% | 97.7% | 71.9% | 80.4% | 85.7% | 144.5% | 108.7% | 102.4% | |
| 41.3% | -44.3% | -88.0% | 19.0% | -7.9% | 5.0% | 51.7% | 4.1% | 25.6% | -15.9% | 8.9% | -36.8% | -4.6% | |
| 1.7% | 3.1% | 1.7% | 4.5% | 0.6% | 1.2% | 18.1% | 9.3% | 41.2% | 21.4% | 43.2% | 25.0% | 32.4% | |
| -1.7% | -3.1% | -1.7% | -4.5% | -0.6% | -1.2% | -18.1% | -8.3% | -41.2% | -21.4% | -43.2% | -25.0% | -32.4% | |
| – | 5.7% | – | – | 3.2% | – | – | 5.3% | – | – | – | 6.7% | – | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 378.7% | 730.8% | 2,174.2% | 13.4% | 27.1% | 26.4% | 39.1% | 726.7% | 71.2% | 3,391.5% | 2.7% | 19.2% | 888.7% | |
| 291.4% | 576.0% | 1,943.2% | -142.0% | -210.5% | -205.6% | -396.5% | 308.0% | -318.8% | 2,960.7% | -652.4% | -505.1% | 398.6% | |
| -87.4% | -154.8% | -231.1% | -155.4% | -237.6% | -232.0% | -435.6% | -419.7% | -390.0% | -430.9% | -655.1% | -524.2% | -490.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.